Montelukast Post-Marketing Comparative Study With Ketotifen (0476-379)
Condition: AsthmaInterventions: Drug: MK0476, montelukast sodium / Duration of Treatment: 4 Weeks; Drug: Comparator: ketotifen / Duration of Treatment: 4 WeeksSponsor: Merck Sharp & Dohme Corp.Completed - verified September 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials